Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Magnera Corporation (MAGN) is a specialty materials company focused on the design and manufacture of nonwoven materials and engineered solutions used in consumer, healthcare, and industrial applications. The company operates primarily within the nonwovens, engineered materials, and specialty films industries, supplying components that are embedded in everyday products rather than sold directly to end consumers. Its core revenue drivers are advanced nonwoven fabrics and material solutions used in hygiene products, medical supplies, wipes, filtration, and industrial applications.
Magnera was formed in 2024 through the combination of Schweitzer‑Mauduit International, Inc. and Berry Global’s Health, Hygiene and Specialties Global Nonwovens and Films business, followed by a corporate rebrand to Magnera Corporation. The company positions itself as a scaled, innovation‑driven materials supplier with a diversified customer base and long‑term supply relationships, leveraging technical expertise and manufacturing scale as key strategic advantages.
Business Operations
Magnera generates revenue through multiple operating segments centered on Health & Hygiene, Consumer Specialties, and Engineered Materials, each serving distinct end markets with tailored material technologies. These segments supply nonwoven substrates, laminates, and films that are integrated into products such as baby diapers, adult incontinence products, medical gowns and drapes, wipes, packaging, and industrial components. Revenue is primarily derived from long‑term contracts and recurring demand tied to essential consumer and healthcare products.
The company operates an integrated global manufacturing network with proprietary nonwoven technologies, material science capabilities, and process engineering expertise. Magnera controls a portfolio of production assets across North America, Europe, South America, and Asia, and maintains ongoing commercial partnerships with multinational consumer goods and healthcare companies. Its operations include wholly owned subsidiaries inherited from both legacy Schweitzer‑Mauduit and Berry Global nonwovens businesses.
Strategic Position & Investments
Magnera’s strategic direction emphasizes organic growth in hygiene and healthcare end markets, operational efficiency, and product innovation focused on lightweighting, performance enhancement, and sustainability. The company continues to invest in advanced nonwoven technologies, including spunlace, spunbond, and specialty composite materials, to meet evolving customer specifications and regulatory requirements.
A key strategic milestone was the acquisition and integration of Berry Global’s Health, Hygiene and Specialties Global Nonwovens and Films business, which significantly expanded Magnera’s scale, geographic reach, and customer base. The company has indicated continued focus on disciplined capital allocation, selective capacity expansions, and innovation aligned with recyclable, biodegradable, and resource‑efficient material solutions.
Geographic Footprint
Magnera is headquartered in North America, with principal executive offices in the United States, and maintains a broad international manufacturing and commercial presence. The company operates production facilities and sales offices across North America, Europe, South America, and Asia, supporting global customers in both developed and emerging markets.
Its diversified geographic footprint reduces reliance on any single region and allows Magnera to serve multinational customers with localized manufacturing, supply chain resilience, and regulatory compliance. International operations contribute a substantial portion of revenue, reflecting the global nature of hygiene, healthcare, and industrial materials demand.
Leadership & Governance
Magnera is led by an executive team with deep experience in specialty materials, global manufacturing, and operational integration following large‑scale mergers. The leadership team emphasizes disciplined execution, customer partnership, and innovation‑driven growth while maintaining a focus on safety, sustainability, and shareholder value creation.
Key executives include:
- Curt Begle – President & Chief Executive Officer
- Laura Schwinn – Chief Financial Officer
- Tom Wulf – Chief Operating Officer
- Lisa Gerkens – Chief Legal Officer & Corporate Secretary
The company is governed by a board of directors composed of independent and executive members with backgrounds in manufacturing, finance, and global operations, supporting oversight aligned with public company governance standards.